Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin M Walton

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Addiction Neuroscience|February 23, 2023
Medication Adherence in Tobacco Cessation Clinical TrialsKevin M Walton, Evan S Herrmann
Drug and Alcohol Dependence|November 5, 2021
Digital therapeutics for Substance Use Disorders: Research priorities and clinical validationWill M Aklin, Kevin M Walton, Patrick Antkowiak
Current Opinion in Drug Discovery & Development|September 28, 2006
Galanin function in the central nervous systemKevin M Walton, Janice E Chin, Allen J Duplantier, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 22, 2009
Selective inhibition of casein kinase 1 epsilon minimally alters circadian clock periodKevin M Walton, Katherine Fisher, David Rubitski, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 11, 2010
Entrainment of disrupted circadian behavior through inhibition of casein kinase 1 (CK1) enzymesQing-Jun Meng, Elizabeth S Maywood, David A Bechtold, et al.
Brain Stimulation|August 30, 2022
Transcutaneous cervical vagus nerve stimulation reduces behavioral and physiological manifestations of withdrawal in patients with opioid use disorder: A double-blind, randomized, sham-controlled pilot studyAsim H Gazi, Anna B Harrison, Tamara P Lambert, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|October 23, 2014
NIH electronic cigarette workshop: developing a research agendaKevin M Walton, David B Abrams, William C Bailey, et al.
Annals of Depression and Anxiety|December 11, 2023
Noninvasive Vagal Nerve Stimulation for Opioid Use DisorderJ Douglas Bremner, Asim H Gazi, Tamara P Lambert, et al.
Biosensors|November 10, 2022
Leveraging Accelerometry as a Prognostic Indicator for Increase in Opioid Withdrawal SymptomsTamara P Lambert, Asim H Gazi, Anna B Harrison, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Addiction Neuroscience|February 23, 2023
Medication Adherence in Tobacco Cessation Clinical TrialsKevin M Walton, Evan S Herrmann
Drug and Alcohol Dependence|November 5, 2021
Digital therapeutics for Substance Use Disorders: Research priorities and clinical validationWill M Aklin, Kevin M Walton, Patrick Antkowiak
Current Opinion in Drug Discovery & Development|September 28, 2006
Galanin function in the central nervous systemKevin M Walton, Janice E Chin, Allen J Duplantier, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 22, 2009
Selective inhibition of casein kinase 1 epsilon minimally alters circadian clock periodKevin M Walton, Katherine Fisher, David Rubitski, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 11, 2010
Entrainment of disrupted circadian behavior through inhibition of casein kinase 1 (CK1) enzymesQing-Jun Meng, Elizabeth S Maywood, David A Bechtold, et al.
Brain Stimulation|August 30, 2022
Transcutaneous cervical vagus nerve stimulation reduces behavioral and physiological manifestations of withdrawal in patients with opioid use disorder: A double-blind, randomized, sham-controlled pilot studyAsim H Gazi, Anna B Harrison, Tamara P Lambert, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|October 23, 2014
NIH electronic cigarette workshop: developing a research agendaKevin M Walton, David B Abrams, William C Bailey, et al.
Annals of Depression and Anxiety|December 11, 2023
Noninvasive Vagal Nerve Stimulation for Opioid Use DisorderJ Douglas Bremner, Asim H Gazi, Tamara P Lambert, et al.
Biosensors|November 10, 2022
Leveraging Accelerometry as a Prognostic Indicator for Increase in Opioid Withdrawal SymptomsTamara P Lambert, Asim H Gazi, Anna B Harrison, et al.
Pageof 1